Medpace Holdings, Inc.

NASDAQ

Market Cap.

8.51B

Avg. Volume

527.45K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Medpace Holdings, Inc.

Medpace Holdings, Inc. News

Medpace Holdings, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Diagnostics & Research
medpace.com

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc. Earnings & Revenue

Medpace Holdings, Inc. Financials

Table Compare

Compare MEDP metrics with:

   

Earnings & Growth

MEDP

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

MEDP

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

MEDP

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

MEDP

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Medpace Holdings, Inc. Income

Medpace Holdings, Inc. Balance Sheet

Medpace Holdings, Inc. Cash Flow

Medpace Holdings, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioSell
Price/Earnings RatioSell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Medpace Holdings, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Medpace Holdings, Inc. Executives

NameRole
Dr. August James Troendle M.D.Chairman & Chief Executive Officer
Ms. Susan E. Burwig BSN, MAExecutive Vice President of Operations
Mr. Jesse J. Geiger BBA, CPAPresident
Mr. Stephen P. Ewald J.D.Chief Compliance Officer, General Counsel & Corporate Secretary
Mr. Kevin M. BradyChief Financial Officer & Treasurer
NameRoleGenderDate of BirthPay
Dr. August James Troendle M.D.Chairman & Chief Executive Officer19561.53M
Ms. Susan E. Burwig BSN, MAExecutive Vice President of OperationsFemale19631.06M
Mr. Jesse J. Geiger BBA, CPAPresidentMale1974939.07K
Mr. Stephen P. Ewald J.D.Chief Compliance Officer, General Counsel & Corporate SecretaryMale1969871.95K
Mr. Kevin M. BradyChief Financial Officer & TreasurerMale1975656.75K

Medpace Holdings, Inc. Insider Trades

Date24 Apr
NameDAVENPORT FRED B JR
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares4710
Date24 Apr
NameDAVENPORT FRED B JR
RoleDirector
TransactionDisposed
TypeS-Sale
Shares1712
Date24 Apr
NameDAVENPORT FRED B JR
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares4710
Date31 Mar
NameMcCarthy Cornelius P. III
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares50
Date31 Mar
NameMcCarthy Cornelius P. III
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares50
DateNameRoleTransactionTypeShares
24 AprDAVENPORT FRED B JRDirectorAcquiredM-Exempt4710
24 AprDAVENPORT FRED B JRDirectorDisposedS-Sale1712
24 AprDAVENPORT FRED B JRDirectorDisposedM-Exempt4710
31 MarMcCarthy Cornelius P. IIIDirectorAcquiredM-Exempt50
31 MarMcCarthy Cornelius P. IIIDirectorDisposedM-Exempt50

Discover More

Streamlined Academy

Medpace Holdings, Inc.

NASDAQ

Market Cap.

8.51B

Avg. Volume

527.45K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Medpace Holdings, Inc. News

Medpace Holdings, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Medpace Holdings, Inc. Earnings & Revenue

Medpace Holdings, Inc. Income

Medpace Holdings, Inc. Balance Sheet

Medpace Holdings, Inc. Cash Flow

Medpace Holdings, Inc. Financials Over Time

Medpace Holdings, Inc. Executives

NameRole
Dr. August James Troendle M.D.Chairman & Chief Executive Officer
Ms. Susan E. Burwig BSN, MAExecutive Vice President of Operations
Mr. Jesse J. Geiger BBA, CPAPresident
Mr. Stephen P. Ewald J.D.Chief Compliance Officer, General Counsel & Corporate Secretary
Mr. Kevin M. BradyChief Financial Officer & Treasurer
NameRoleGenderDate of BirthPay
Dr. August James Troendle M.D.Chairman & Chief Executive Officer19561.53M
Ms. Susan E. Burwig BSN, MAExecutive Vice President of OperationsFemale19631.06M
Mr. Jesse J. Geiger BBA, CPAPresidentMale1974939.07K
Mr. Stephen P. Ewald J.D.Chief Compliance Officer, General Counsel & Corporate SecretaryMale1969871.95K
Mr. Kevin M. BradyChief Financial Officer & TreasurerMale1975656.75K

Medpace Holdings, Inc. Insider Trades

Date24 Apr
NameDAVENPORT FRED B JR
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares4710
Date24 Apr
NameDAVENPORT FRED B JR
RoleDirector
TransactionDisposed
TypeS-Sale
Shares1712
Date24 Apr
NameDAVENPORT FRED B JR
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares4710
Date31 Mar
NameMcCarthy Cornelius P. III
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares50
Date31 Mar
NameMcCarthy Cornelius P. III
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares50
DateNameRoleTransactionTypeShares
24 AprDAVENPORT FRED B JRDirectorAcquiredM-Exempt4710
24 AprDAVENPORT FRED B JRDirectorDisposedS-Sale1712
24 AprDAVENPORT FRED B JRDirectorDisposedM-Exempt4710
31 MarMcCarthy Cornelius P. IIIDirectorAcquiredM-Exempt50
31 MarMcCarthy Cornelius P. IIIDirectorDisposedM-Exempt50

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
medpace.com

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Medpace Holdings, Inc.

Medpace Holdings, Inc. Financials

Table Compare

Compare MEDP metrics with:

   

Earnings & Growth

MEDP

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

MEDP

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

MEDP

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

MEDP

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Medpace Holdings, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioSell
Price/Earnings RatioSell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)